Streetbeat News

Analyst Ratings

CRWD

Cantor Fitzgerald analyst Yi Fu Lee has reiterated an Overweight rating on CrowdStrike Holdings (CRWD) and maintained a price target of $360.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:41 pm

BIIB

Needham analyst Ami Fadia reiterated a Buy rating on Biogen (NASDAQ:BIIB) and maintained a $305 price target.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:34 pm

CNK

Wedbush analyst Alicia Reese reiterates an Outperform rating on Cinemark Holdings (CNK) and maintains a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:28 pm

GTHX

Wedbush analyst David Nierengarten maintains an Outperform rating on G1 Therapeutics (NASDAQ:GTHX) but lowers the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:27 pm

CBAY

BTIG analyst Julian Harrison downgraded CymaBay Therapeutics (NASDAQ:CBAY) from Buy to Neutral, indicating a shift in the firm's outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:16 pm

ANTX

CDNS

GTHX

LSCC

MNDY

NAPA

PLCE

PYPL

TRMB

ZI

Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including monday.com, G1 Therapeutics, Cadence Design Systems, The Children's Place, AN2 Therapeutics, Lattice Semiconductor, Trimble, ZoomInfo Technologies, PayPal Holdings, and The Duckhorn Portfolio. These changes reflect analysts' latest views on these stocks, with some experiencing upgrades and others downgrades.

Portfolio Pulse from Avi Kapoor

February 13, 2024 | 1:08 pm

CDNS

Rosenblatt analyst Blair Abernethy downgraded Cadence Design Systems (CDNS) from Buy to Neutral but increased the price target from $265 to $280.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:06 pm

TWOU

Needham analyst Ryan MacDonald downgrades 2U (NASDAQ:TWOU) from Buy to Hold, indicating a change in the firm's outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:04 pm

NAPA

B of A Securities analyst Peter Galbo downgraded Duckhorn Portfolio (NYSE:NAPA) from Neutral to Underperform and reduced the price target from $11 to $8.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 1:01 pm

PLCE

Analyst ratings for Children's Place (NASDAQ:PLCE) show a bearish trend with a significant decrease in the average 12-month price target from $29.75 to $15.00, a 49.58% drop. Recent actions by analysts include lowering ratings and price targets, reflecting concerns over the company's performance and market conditions. Despite challenges in revenue growth and a high debt-to-equity ratio, Children's Place maintains a strong market position with a notable net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 1:00 pm